Kentaro Suzuki

Insider Reports History

Location
Seattle, WA
Signature
/s/ Matthew Murphy, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kentaro Suzuki:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nautilus Biotechnology, Inc. Chief Marketing Officer Common Stock 4,000 $5,960 $1.49 06 Nov 2025 Direct
Nautilus Biotechnology, Inc. Chief Marketing Officer Stock Option (Right to Buy) 50,000 03 Mar 2025 Direct

Insider Reports Filed by Kentaro Suzuki

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NAUT Nautilus Biotechnology, Inc. 06 Nov 2025 1 +$5,960 4 Chief Marketing Officer 10 Nov 2025, 21:29
NAUT Nautilus Biotechnology, Inc. 03 Mar 2025 1 $0 4 Chief Marketing Officer 04 Mar 2025, 16:52
NAUT Nautilus Biotechnology, Inc. 16 Sep 2024 1 $0 4 Chief Marketing Officer 17 Sep 2024, 16:47
NAUT Nautilus Biotechnology, Inc. 16 Sep 2024 0 $0 3 Chief Marketing Officer 17 Sep 2024, 16:40